Comments to FDA: OTC Drug Products Share page: Docket Number: 00N-1256 This submission represents CHPA's detailed written comments as follow-up to the June meeting and is intended to complement the Association's oral presentation. Download Document Issues: OTC Medicines Rx-to-OTC Switch Related Posts Articles Polibrief: Post-Consumer Recycled Content Jul 9, 2024 Press Releases and Statements CHPA Statement on U.S. Supreme Court Overturning the Chevron Standard Jun 28, 2024 Press Releases and Statements CHPA Welcomes New Board Members at June Meeting Jun 14, 2024